Despite being initially suggested as a marker for liver function impairment severity, recent studies have found that the AST/ALT ratio is linked to mortality in a variety of patient subgroups, including myocardial infarction, cardiac arrest, heart failure, sepsis, hypertension, type 2 diabetes, and even COVID-19 patients [10, 15–23]. The gene discussed is GPT; the disease is heart failure.